Patients who undergo a radical prostatectomy due to prostate cancer may subsequently experience uncertainty about whether the cancer has been completely removed from the body. In Aarhus, patients with increased PSA after surgery are often referred to supplementary radiotherapy at the Department of Oncology.
There is general disagreement about whether it is most effective to give supplementary radiotherapy shortly after the operation, or whether the effect is just as good or better when delaying the radiotherapy until the patient has a PSA increase as a sign of the relapse of the disease.
Radicals is a European randomised controlled trial which examines when the best effect is achieved by offering the patients supplementary radiotherapy and whether receiving hormone treatment in addition to the radiotherapy has an effect.
Oncological Consultant at Rigshospitalet Peter Meindahl is the head of the trial in Denmark.
The trial is ongoing but new test subjects are no longer required.
The trial is conducted in collaboration with: Department of Oncology, Aarhus University Hospital Sponsor Investigator: Consultant Simon Buus
